Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|September 19, 2023
Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectivesClaire E Wakefield, Kate Hetherington, Eden G Robertson, et al.
International Journal of Molecular Sciences|November 14, 2023
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven NeuroblastomaLei Zhai, Anushree Balachandran, Rebecca Larkin, et al.
Cancers|April 23, 2022
Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian CancerJixuan Gao, MoonSun Jung, Rebekka T Williams, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Leukemia|April 25, 2021
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemiaJulia W Bӧhm, Keith C S Sia, Connor Jones, et al.
Plos Genetics|June 24, 2011
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityGlenn M Marshall, Pei Y Liu, Samuele Gherardi, et al.
Cancers|July 12, 2025
Bridging the Gap: Embedding Psychosocial Oncology Research into Comprehensive Cancer Care for Children and Young PeopleUrsula Margaret Sansom-Daly, Jordana Kathleen McLoone, Joanna Elizabeth Fardell, et al.
Cancer Cell|June 20, 2020
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid LeukemiaBasit Salik, Hangyu Yi, Nunki Hassan, et al.
British Journal of Cancer|September 2, 2021
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcomaVinod Vijay Subhash, Libby Huang, Alvin Kamili, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|September 19, 2023
Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectivesClaire E Wakefield, Kate Hetherington, Eden G Robertson, et al.
International Journal of Molecular Sciences|November 14, 2023
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven NeuroblastomaLei Zhai, Anushree Balachandran, Rebecca Larkin, et al.
Cancers|April 23, 2022
Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian CancerJixuan Gao, MoonSun Jung, Rebekka T Williams, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Leukemia|April 25, 2021
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemiaJulia W Bӧhm, Keith C S Sia, Connor Jones, et al.
Plos Genetics|June 24, 2011
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityGlenn M Marshall, Pei Y Liu, Samuele Gherardi, et al.
Cancers|July 12, 2025
Bridging the Gap: Embedding Psychosocial Oncology Research into Comprehensive Cancer Care for Children and Young PeopleUrsula Margaret Sansom-Daly, Jordana Kathleen McLoone, Joanna Elizabeth Fardell, et al.
Cancer Cell|June 20, 2020
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid LeukemiaBasit Salik, Hangyu Yi, Nunki Hassan, et al.
British Journal of Cancer|September 2, 2021
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcomaVinod Vijay Subhash, Libby Huang, Alvin Kamili, et al.
Pageof 19